Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

NCT02187081 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
380
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Southwest Hospital, China